Supplementary Table S1 from A Proof-of-Concept Study of Sequential Treatment with the HDAC Inhibitor Vorinostat following BRAF and MEK Inhibitors in <i>BRAF</i><sup><i>V600</i></sup>-Mutated Melanoma
收藏NIAID Data Ecosystem2026-05-02 收录
数据链接：
官方服务：
资源简介：
Supplementary Table S1. Representativeness of study participants.
创建时间：
2024-08-01
